Third Pfizer Covid Shot Said To Have Similar Side Effects To Second

Bloomberg: Pfizer Booster Causes Similar Side Effects to Second Dose: Study
Most people who got a booster shot of the Pfizer Inc.-BioNTech SE Covid-19 vaccine had similar or fewer side effects than they did after the second dose, according to a preliminary study conducted by Israel’s largest health maintenance organization. Of the 4,500 respondents to the survey, 88% reported “a similar or better feeling” than their reaction to the previous dose, with 31% saying they had localized effects like pain or swelling in the area of injection, according to a statement from Clalit Health Services late Sunday. About 15% of people had other symptoms like tiredness, muscle aches or fever. Less than 1% reported difficulty breathing or chest pains. (Benmeleh, 8/9)

Stat: Scientist Debate Potential Benefits Of Intranasal Covid-19 Vaccines
As the world amasses experience with Covid-19 vaccines, something we should have known from the start is coming into sharp focus. Vaccines that are injected into arm muscles aren’t likely to be able to protect our nasal passages from marauding SARS-CoV-2 viruses for very long, even if they are doing a terrific job protecting lungs from the virus. If we want vaccines that protect our upper respiratory tracts, we may need products that are administered in the nose — intranasal vaccines. (Branswell, 8/10)

Louisville Courier Journal: CDC Study Disputes Rand Paul, Thomas Massie COVID-19 Immunity Claims
Two Republican members of Congress from Kentucky — Sen. Rand Paul and Rep. Thomas Massie — have steadfastly refused to get the COVID-19 vaccine, saying they have natural immunity because they had the viral infection. But a new study from the U.S. Centers for Disease Control and Prevention, based on data from people in Kentucky who contracted COVID-19 a second time, says the vaccine boosts immunity in people who have had the virus. Unvaccinated people who contracted COVID-19 are more than twice as likely to catch it again than those who got vaccinated after contracting the virus, it said. (Yetter, 8/9)

In updates on the vaccine rollout —

Des Moines Register: Iowa Is Throwing Away Thousands Of COVID-19 Shots For Lack Of Demand
Iowa has started tossing out tens of thousands of expiring COVID vaccine doses as demand for the shots continues to sag. The state has discarded 81,186 doses of the vaccine so far, said Sarah Ekstrand, spokesperson for the Iowa Department of Public Health. That includes doses that expired, plus some that were wasted for other reasons, such as when a multiple-dose vial was opened and couldn't be used up quickly enough. (Leys, 8/9)

AP: California To Offer Vaccine Incentive To Medicaid Population
California announced another round of coronavirus vaccine incentives on Friday, offering up to $50 apiece to more than 11 million people in the state who get their health insurance through Medicaid. The money is part of a new $350 million plan to get more of the state’s Medicaid population vaccinated as the state is seeing a surge of new cases attributed to the delta variant, a more contagious and dangerous version of the coronavirus. Medicaid is the joint state and federal health insurance program for people who are disabled or have low incomes. (Beam, 8/9)

Philadelphia Inquirer: Pa. Is Trying County Fairs, Text Messages, And Door-Knocking To Raise The Vaccination Rate. Success Is Slow Coming
Nicole Diehl attended the Wayne County Fair in northeastern Pennsylvania last weekend, not for the livestock exhibitions, carnival games, demolition derbies, or tractor pulls. Instead, the registered nurse was on hand as part of an effort to make it as easy as possible to get vaccinated — a goal that’s become even more critical as new cases of COVID-19 creep up in Pennsylvania. “It’s right here, they know it’s free, let’s just do it and get it done with,” said Diehl, a 21-year veteran of the Wayne Memorial Health System, which is organizing the clinics. “I do believe convenience plays a big part in it.” (Martines, 8/10)

CNN: FDA Approval Of The Covid-19 Vaccine Could Mean More People Will Get Vaccinated For An Unexpected Reason 
Pfizer's Covid-19 vaccine is currently only authorized for emergency use in the United States, but its full approval by the US Food and Drug Administration could happen within weeks. The ramifications could alter the course of the pandemic in several ways. First, full approval of a Covid-19 vaccine could persuade more people to get vaccinated. (Christensen, 8/9)